Showing results (181-190 of 213) with videos related to
Sort By:
Pageof 22
Journal of Psychiatric Research|November 2, 2025
The effects of ketamine and esketamine on functional outcomes in major depressive disorder and treatment-resistant depression: A systematic reviewIsabella S Ji, Morgan C H Cheng, Kayla M Teopiz, et al.Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Greater Role of Cognitive Impairment Over Fatigue in Post-COVID-19 Quality of Life: A Post-Hoc Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.Current Medical Research and Opinion|July 2, 2024
Relationship between anhedonia and psychosocial functioning in post-COVID-19 condition: a <i>post-hoc</i> analysisSonya Liao, Kayla M Teopiz, Angela T H Kwan, et al.Journal of Affective Disorders|October 17, 2025
Effects of glutamatergic modulators on striatal activation, functional connectivity and reward in persons with major depressive disorder and healthy controls: A systematic review of fMRI studiesKayla M Teopiz, Sabrina Wong, Gia Han Le, et al.European Archives of Psychiatry and Clinical Neuroscience|August 27, 2024
Subjective and objective measures of cognitive function are correlated in persons with Post-COVID-19 Condition: a secondary analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Subjective and Objective Measures of Cognitive Function are Correlated in Persons with Post-COVID-19 Condition: A Secondary Analysis of a Randomized Controlled TrialAngela T H Kwan, Moiz Lakhani, Gia Han Le, et al.CNS Spectrums|December 10, 2024
Impact of depressive symptoms on motivation in persons with post-COVID-19 conditionJuliana West, Angela T H Kwan, Kayla M Teopiz, et al.CNS Spectrums|June 9, 2025
Glucagon-like Peptide-1 receptor agonists for the prevention and treatment of Parkinson's diseaseSerene Lee, Liyang Yin, Naomi Xiao, et al.Journal of Affective Disorders|April 3, 2024
Spectral signatures of psilocybin, lysergic acid diethylamide (LSD) and ketamine in healthy volunteers and persons with major depressive disorder and treatment-resistant depression: A systematic reviewGia Han Le, Sabrina Wong, Sebastian Badulescu, et al.The Journal of Clinical Psychiatry|September 3, 2025
Comparing the Cognitive Effects of Repeated Intravenous Ketamine and Electroconvulsive Therapy in Patients With Treatment-Resistant Depression: A Secondary Analysis of the ELEKT-D TrialKristina T Kumpf, Samuel T Wilkinson, Bo Hu, et al.Pageof 22